Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-01 Option Award | 2025-04-03 4:32 pm | N/A 2035-03-31 | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 15,616 | $0 | 15,616 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:30 pm | N/A 2035-03-31 | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 35,209 | $0 | 35,209 (Direct) | View |
Ownership | 2025-04-03 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 0 | $0 | 169,340 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 5:36 pm | N/A 2035-02-28 | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 31,900 | $0 | 31,900 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 5:31 pm | N/A 2035-02-28 | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 93,693 | $0 | 93,693 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 5:28 pm | N/A 2035-02-28 | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 109,309 | $0 | 109,309 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 5:24 pm | N/A 2035-02-28 | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 78,078 | $0 | 78,078 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 5:21 pm | N/A 2035-02-28 | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 140,540 | $0 | 140,540 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 5:13 pm | N/A 2035-02-28 | Acrivon Therapeutics Inc. | ACRV | Cuillerot Jean-Marie Chief Medical Officer | 78,078 | $0 | 78,078 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 5:11 pm | N/A 2035-02-28 | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 530,930 | $0 | 530,930 (Direct) | View |
| 2025-02-21 Tax Withholding | 2025-02-25 4:09 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 19,904 | $5.54 | 2,601,958 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 5:00 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 116 | $5.42 | 4,419 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:59 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 217 | $5.42 | 37,065 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:55 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 434 | $5.42 | 26,088 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:54 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 469 | $5.42 | 16,492 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:53 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 724 | $5.42 | 67,147 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:52 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 37,731 | $5.42 | 2,621,862 (Direct) | View |
| 2025-01-17 Tax Withholding | 2025-01-22 4:15 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 659 | $5.78 | 37,282 (Direct) | View |
| 2024-03-01 Option Award | 2024-11-27 6:11 pm | N/A 2034-02-28 | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 67,567 | $0 | 67,567 (Direct) | View |
| 2024-03-01 Option Award | 2024-11-27 6:10 pm | N/A 2034-02-28 | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 90,090 | $0 | 90,090 (Direct) | View |
| 2024-03-01 Option Award | 2024-11-27 6:08 pm | N/A 2034-02-28 | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 45,045 | $0 | 45,045 (Direct) | View |
| 2024-03-01 Option Award | 2024-11-27 6:06 pm | N/A 2034-02-28 | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 90,090 | $0 | 90,090 (Direct) | View |
| 2024-03-01 Option Award | 2024-11-27 6:04 pm | N/A 2034-02-28 | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 315,316 | $0 | 315,316 (Direct) | View |
| 2024-11-21 Tax Withholding | 2024-11-25 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 19,910 | $6.44 | 2,659,593 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:32 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $7.92 | 4,535 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:31 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 184 | $7.92 | 37,941 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:30 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 368 | $7.92 | 26,522 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 402 | $7.92 | 16,961 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $7.92 | 67,871 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:26 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 60,256 | $7.92 | 2,679,503 (Direct) | View |
| 2024-10-17 Tax Withholding | 2024-10-21 4:22 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 558 | $7.87 | 38,125 (Direct) | View |
| 2024-10-01 Tax Withholding | 2024-10-03 6:49 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 284 | $6.98 | 38,683 (Direct) | View |
| 2024-08-21 Tax Withholding | 2024-08-23 4:11 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 79,616 | $9.19 | 2,739,759 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:53 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $7.02 | 4,634 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:52 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 184 | $7.02 | 38,967 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:52 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Masson Kristina EVP - Business Operations | 490 | $7.02 | 2,819,375 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:51 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 368 | $7.02 | 26,890 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:50 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 402 | $7.02 | 17,363 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:48 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $7.02 | 68,484 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:47 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO | 59,765 | $7.02 | 2,819,375 (Direct) | View |